comparemela.com

Latest Breaking News On - Cure trading down - Page 2 : comparemela.com

AtriCure (NASDAQ:ATRC) Rating Increased to Outperform at Oppenheimer

Oppenheimer upgraded shares of AtriCure (NASDAQ:ATRC – Free Report) from a market perform rating to an outperform rating in a research note published on Tuesday morning, Marketbeat.com reports. Oppenheimer currently has $32.00 price objective on the medical device company’s stock. A number of other research analysts also recently commented on ATRC. Stifel Nicolaus lowered their […]

AtriCure (NASDAQ:ATRC) Raised to Outperform at Oppenheimer

Oppenheimer upgraded shares of AtriCure (NASDAQ:ATRC – Free Report) from a market perform rating to an outperform rating in a research note published on Tuesday, MarketBeat Ratings reports. They currently have $32.00 price objective on the medical device company’s stock. Several other brokerages have also issued reports on ATRC. Stifel Nicolaus lowered their price target […]

AtriCure (NASDAQ:ATRC) Sets New 1-Year Low at $25 76

Shares of AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $25.76 and last traded at $25.92, with a volume of 593921 shares trading hands. The stock had previously closed at $27.61. Analyst Upgrades and Downgrades ATRC has been the […]

NovoCure (NASDAQ:NVCR) Price Target Cut to $42 00

NovoCure (NASDAQ:NVCR – Free Report) had its target price trimmed by Wells Fargo & Company from $49.00 to $42.00 in a report issued on Wednesday morning, Benzinga reports. The brokerage currently has an overweight rating on the medical equipment provider’s stock. Other analysts have also recently issued research reports about the company. HC Wainwright upped […]

AtriCure (NASDAQ:ATRC) Hits New 12-Month Low at $27 86

AtriCure (NASDAQ:ATRC) Hits New 12-Month Low at $27 86
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.